Ir al contenido
· Rellenos dérmicos
SKU 10970

Olidia 240

En stock
Volumen
1 x 243,4 mg
Laboratorio
PRP Life Science Co., Ltd.
Origen
Corea del Sur
Indicación
Moderate to severe nasolabial folds
Zonas de tratamiento
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.

Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.

Principales ventajas de Olidia 240

  • Improves moderate to severe nasolabial folds
  • PLLA-based formulation designed for a gradual tissue response after injection
  • For professional injection into the deep dermis or subdermal layer
  • CE-marked medical device (CE 1434)
Información clave
Marca OLIDIA
Fabricante PRP Life Science Co., Ltd.
País de origen South Korea
Certificación CE-marked (CE 1434)
Composición Poly-L-lactic acid (PLLA), carboxymethylcellulose (CMC), mannitol - 243.4 mg total per vial
Volumen / Tamaño 1 vial per box (243.4 mg)
Tipo de uso Professional use only - licensed practitioner administration
Profundidad de inyección Deep dermis and subdermal layer

Indicaciones y uso profesional

Indicaciones principales

  • Moderate to severe nasolabial folds

Uso profesional

For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.

Zonas de tratamiento

  • Moderate to severe nasolabial folds.

Perfil del paciente

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

Cómo funciona Olidia 240 ​

Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.

Por qué comprar en Allpara

Allpara ofrece productos OLIDIA originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What is Olidia 240 used for?

Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.

What is in the Olidia 240 formula?

Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.

Where is Olidia 240 injected?

Olidia 240 is injected into the deep dermis or subdermal layer.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
OLIDIA
Laboratorio
PRP Life Science Co., Ltd.
SKU
10970
Formato
1 x 243,4 mg
Origen
Corea del Sur
Indicación
Moderate to severe nasolabial folds
Uso
Professional injectable poly-L-lactic acid (PLLA) dermal filler, 243.4 mg per vial, deep dermis / subdermal layer
Zonas de tratamiento
/ Detalles del producto

El expediente completo

Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.

PRP Life Science Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What is Olidia 240 used for?

Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.

What is in the Olidia 240 formula?

Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.

Where is Olidia 240 injected?

Olidia 240 is injected into the deep dermis or subdermal layer.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
/ FAQ

Preguntas frecuentes

Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Olidia 240 is injected into the deep dermis or subdermal layer.

Más productos de PRP Life Science

Ver laboratorio

Alternativas para la clínica

Todos los productos

Olidia 240

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.

Principales ventajas de Olidia 240

  • Improves moderate to severe nasolabial folds
  • PLLA-based formulation designed for a gradual tissue response after injection
  • For professional injection into the deep dermis or subdermal layer
  • CE-marked medical device (CE 1434)
Información clave
Marca OLIDIA
Fabricante PRP Life Science Co., Ltd.
País de origen South Korea
Certificación CE-marked (CE 1434)
Composición Poly-L-lactic acid (PLLA), carboxymethylcellulose (CMC), mannitol - 243.4 mg total per vial
Volumen / Tamaño 1 vial per box (243.4 mg)
Tipo de uso Professional use only - licensed practitioner administration
Profundidad de inyección Deep dermis and subdermal layer

Indicaciones y uso profesional

Indicaciones principales

  • Moderate to severe nasolabial folds

Uso profesional

For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.

Zonas de tratamiento

  • Moderate to severe nasolabial folds.

Perfil del paciente

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

Cómo funciona Olidia 240 ​

Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.

Por qué comprar en Allpara

Allpara ofrece productos OLIDIA originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What is Olidia 240 used for?

Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.

What is in the Olidia 240 formula?

Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.

Where is Olidia 240 injected?

Olidia 240 is injected into the deep dermis or subdermal layer.

Más productos de PRP Life Science

Ver el laboratorio →

Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.

PRP Life Science Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What is Olidia 240 used for?

Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.

What is in the Olidia 240 formula?

Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.

Where is Olidia 240 injected?

Olidia 240 is injected into the deep dermis or subdermal layer.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.